PRESS RELEASE published on 09/02/2026 at 15:46, 5 days 15 hours ago Form 8.3 - The Vanguard Group, Inc.: Prologis, Inc. The Vanguard Group, Inc. discloses 13.49% ownership in Prologis, Inc. and dealings in USD 0.01 common securities Financial Dealings The Vanguard Group Ownership Disclosure Prologis Inc. USD Common Securities
PRESS RELEASE published on 09/02/2026 at 15:45, 5 days 15 hours ago Form 8.3 - The Vanguard Group, Inc.: DCC plc The Vanguard Group, Inc. discloses a 5.84% stake in DCC plc. Details of securities owned and recent purchases disclosed under Rule 8.3 of Irish Takeover Panel Act Securities Irish Takeover Panel The Vanguard Group Rule 8.3 DCC Plc
PRESS RELEASE published on 09/02/2026 at 15:45, 5 days 15 hours ago Form 8.3 - The Vanguard Group, Inc.: Beazley plc The Vanguard Group, Inc. discloses 5.00% ownership in Beazley plc. Form 8.3 filed under Rule 8.3 of the Takeover Code Form 8.3 The Vanguard Group Takeover Code Ownership Disclosure Beazley Plc
PRESS RELEASE published on 09/02/2026 at 15:44, 5 days 15 hours ago Form 8.3 - The Vanguard Group, Inc.: Schroders plc The Vanguard Group, Inc. discloses a 2.72% ownership in Schroders plc in a Form 8.3 filing according to the Takeover Code Form 8.3 The Vanguard Group Takeover Code Schroders Plc Ownership Disclosure
PRESS RELEASE published on 09/02/2026 at 15:44, 5 days 15 hours ago Form 8.3 - The Vanguard Group, Inc.: Tate & Lyle plc The Vanguard Group, Inc. discloses 4.78% stake in Tate & Lyle plc per Form 8.3 filing. No other disclosures made. Date of disclosure: 02 September 2026 Financial News Form 8.3 The Vanguard Group Stake Disclosure Tate & Lyle Plc
PRESS RELEASE published on 09/02/2026 at 15:43, 5 days 15 hours ago Form 8.3 - The Vanguard Group, Inc.: Spire Healthcare Group plc The Vanguard Group, Inc. discloses a 3.57% interest in Spire Healthcare Group plc through a Form 8.3 filing, including purchase of 47,052 securities at 2.37 GBP per unit Securities Form 8.3 The Vanguard Group Purchase Spire Healthcare Group Plc
PRESS RELEASE published on 09/02/2026 at 15:43, 5 days 15 hours ago Form 8.3 - The Vanguard Group, Inc.: easyJet plc The Vanguard Group, Inc. discloses 3.15% interest in easyJet plc per Form 8.3. Details on securities positions and dealings provided Securities Form 8.3 Vanguard Group EasyJet Plc Disclosures
PRESS RELEASE published on 09/02/2026 at 15:42, 5 days 15 hours ago Form 8.3 - The Vanguard Group, Inc.: SEGRO plc The Vanguard Group, Inc. discloses a 5.68% interest in SEGRO plc. Purchase of 10p ordinary shares made at GBP 9.51, 9.52, and 9.53 Vanguard Group Purchase 10p Ordinary Shares SEGRO PLC GBP 9.51
PRESS RELEASE published on 09/02/2026 at 15:42, 5 days 15 hours ago Form 8.3 - The Vanguard Group, Inc.: LondonMetric Property plc The Vanguard Group, Inc. discloses a 5.32% ownership in LondonMetric Property plc and a 0.95% ownership in Schroder Real Estate Investment Trust Limited The Vanguard Group, Inc. LondonMetric Property Plc Ownership Disclosure Financial Holdings Schroder Real Estate Investment Trust Limited
PRESS RELEASE published on 09/02/2026 at 15:41, 5 days 15 hours ago Form 8.3 - The Vanguard Group, Inc.: Intertek Group plc The Vanguard Group, Inc. discloses a 5.70% interest in Intertek Group plc's 1p ordinary securities. Details of holdings and recent dealings revealed Securities Disclosure The Vanguard Group Dealings Intertek Group Plc
Published on 09/08/2026 at 01:45, 5 hours 45 minutes ago Tunkillia Environmental Scoping Report Approved
Published on 09/05/2026 at 04:05, 3 days 3 hours ago Pelican AI Corp. Announces Proposed Share Issuances and Litigation Update
Published on 09/04/2026 at 23:30, 3 days 8 hours ago FutureGen Industries Announces Shares for Debt Settlement
Published on 09/04/2026 at 23:00, 3 days 8 hours ago Golden Minerals Announces Management Change and Argentine Project Update
Published on 09/04/2026 at 22:30, 3 days 9 hours ago Panther Minerals Closes Brokered Private Placement of $3,000,000
Published on 09/08/2026 at 07:05, 25 minutes ago Sandoz invests in new drug substance facility in Ljubljana, Slovenia, to expand biosimilar manufacturing capacity
Published on 09/08/2026 at 07:00, 30 minutes ago Sandoz hosts Capital Markets Day and unveils Bio100 ambition – maximising Sandoz value in its golden decade for biosimilars
Published on 09/08/2026 at 07:00, 30 minutes ago Newron reports subscription for EUR 5.5 million of shares by investor group as part of up to EUR 38 million total financing to advance Phase 3 evenamide program
Published on 09/08/2026 at 06:20, 1 hour 9 minutes ago Guanlan AI Applications: Higher Accuracy, Lower Cost, Smarter Interaction
Published on 09/07/2026 at 19:00, 12 hours 30 minutes ago Informations relatives au nombre total de droits de vote et d’actions composant le capital social au 4 septembre 2026
Published on 09/07/2026 at 19:00, 12 hours 30 minutes ago Information concerning the total number of voting rights and shares in the share capital as of September 4, 2026
Published on 09/07/2026 at 18:05, 13 hours 25 minutes ago AXA: Information relating to the number of voting rights and shares making up the share capital on 31/08/2026
Published on 09/07/2026 at 18:05, 13 hours 25 minutes ago AXA : Information relative au nombre total de droits de vote et d'actions composant le capital social au 31/08/2026
